Beta Wealth Group, Inc. Bristol Myers Squibb CO Transaction History

Beta Wealth Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$40.25 - $52.99 $32,159 - $42,339	799 Added 12.66%	7,111 $295,000
Q1 2024 May 14, 2024	BUY	$47.98 - $54.4 $4,222 - $4,787	88 Added 1.41%	6,312 $342,000
Q4 2023 Feb 09, 2024	BUY	$48.48 - $57.85 $1,066 - $1,272	22 Added 0.35%	6,224 $319,000
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $11,693 - $13,075	202 Added 3.37%	6,202 $359,000
Q2 2023 Aug 11, 2023	BUY	$63.71 - $70.74 $70,081 - $77,814	1,100 Added 22.45%	6,000 $383,000
Q1 2023 May 09, 2023	BUY	$65.71 - $74.53 $26,283 - $29,812	400 Added 8.89%	4,900 $339,000
Q4 2022 Feb 10, 2023	BUY	$68.48 - $81.09 $308,160 - $364,905	4,500 New	4,500 $323,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Beta Wealth Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Beta Wealth Group, Inc. with notifications on news.